ResMed Inc. (RMD) Earnings History
Growth Compounder33 years of earnings data (1993–2025) · Consistent double-digit EPS growth over 5 years
Loading earnings history...
ResMed Inc. (RMD) Earnings Overview
As of June 23, 2026, ResMed Inc. (RMD) reported trailing twelve-month net income of $1.52B, reflecting +37.4% year-over-year growth. The company earned $10.33 per diluted share over the past four quarters, with a net profit margin of 27.2%.
Looking at the long-term picture, RMD's 5-year EPS compound annual growth rate (CAGR) stands at +17.4%, indicating exceptional earnings growth. The company achieved its highest annual net income of $1.40B in fiscal 2025, representing a new all-time high.
ResMed Inc. maintains industry-leading profitability with a gross margin of 59.4%, operating margin of 32.7%, and net margin of 27.2%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including PHG ($972M net income, 5.0% margin), ITGR ($142M net income, 5.6% margin), NVCR (-$173M net income, -20.8% margin), RMD has outperformed on profitability metrics. Compare RMD vs PHG →
RMD Earnings vs Peers
Earnings metrics vs comparable public companies
RMD Historical Earnings Data (1993–2025)
33 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.40B | +37.2% | $1.69B | $9.51 | 27.2% | 32.7% |
| 2024 | $1.02B | +13.7% | $1.32B | $6.92 | 21.8% | 28.2% |
| 2023 | $898M | +15.2% | $1.13B | $6.09 | 21.3% | 26.8% |
| 2022 | $779M | +64.3% | $1.00B | $5.30 | 21.8% | 28.0% |
| 2021 | $475M | -23.7% | $904M | $3.24 | 14.8% | 28.3% |
| 2020 | $622M | +53.7% | $810M | $4.27 | 21.0% | 27.4% |
| 2019 | $405M | +28.2% | $579M | $2.80 | 15.5% | 22.2% |
| 2018 | $316M | -7.8% | $542M | $2.19 | 13.5% | 23.2% |
| 2017 | $342M | -2.9% | $426M | $2.40 | 16.6% | 20.6% |
| 2016 | $352M | -0.1% | $429M | $2.49 | 19.2% | 23.3% |
| 2015 | $353M | +2.2% | $409M | $2.47 | 21.0% | 24.4% |
| 2014 | $345M | +12.4% | $405M | $2.39 | 22.2% | 26.1% |
| 2013 | $307M | +20.5% | $355M | $2.10 | 20.3% | 23.4% |
| 2012 | $255M | +12.3% | $294M | $1.71 | 18.6% | 21.5% |
| 2011 | $227M | +19.4% | $267M | $1.44 | 18.3% | 21.5% |
| 2010 | $190M | +29.8% | $240M | $1.23 | 17.4% | 22.0% |
| 2009 | $146M | +32.8% | $190M | $0.95 | 15.9% | 20.7% |
| 2008 | $110M | +66.4% | $143M | $0.70 | 13.2% | 17.1% |
| 2007 | $66M | -24.8% | $90M | $0.43 | 9.3% | 12.6% |
| 2006 | $88M | +36.2% | $131M | $0.58 | 14.5% | 21.6% |
| 2005 | $65M | +13.1% | $97M | $0.46 | 15.2% | 22.9% |
| 2004 | $57M | +25.3% | $85M | $0.41 | 16.9% | 25.2% |
| 2003 | $46M | +21.9% | $67M | $0.33 | 16.7% | 24.6% |
| 2002 | $38M | +222.5% | -$51M | $0.28 | 18.4% | -25.1% |
| 2001 | $12M | -47.7% | $26M | $0.09 | 7.5% | 16.8% |
| 2000 | $22M | +38.0% | $33M | $0.17 | 19.2% | 28.7% |
| 1999 | $16M | +51.9% | $25M | $0.13 | 18.2% | 28.6% |
| 1998 | $11M | +41.3% | $17M | $0.09 | 15.9% | 26.0% |
| 1997 | $8M | +66.7% | $8M | $0.06 | 15.2% | 16.9% |
| 1996 | $5M | +60.7% | $4M | $0.04 | 13.0% | 10.7% |
| 1995 | $3M | +133.3% | $3M | $0.04 | 11.9% | 11.9% |
| 1994 | $1M | +50.0% | $1M | $0.02 | 8.6% | 9.4% |
| 1993 | $800,000 | - | $700,000 | $0.01 | 10.4% | 9.1% |
Download Data
Export RMD earnings history in CSV or JSON format
Free sign-in required to download data
Full Stock Analysis
Deep dive into RMD consensus models and risk factors.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
33+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
RMD — Frequently Asked Questions
Quick answers to the most common questions about buying RMD stock.
What is RMD earnings per share (EPS)?
RMD trailing twelve-month (TTM) diluted EPS is $10.33, reflecting +37.4% year-over-year growth. The 5-year EPS CAGR is +17.4%. Complete EPS history from 1993 to 2025 is available in the table on this page.
What is ResMed Inc.'s net income?
ResMed Inc. (RMD) trailing twelve-month net income is $1.5B as of 2025. Earnings grew +37.4% year-over-year. ResMed Inc. has been profitable for 33 consecutive years.
Is RMD profitable?
Yes, RMD is profitable with a TTM net income of $1.5B and a net profit margin of +27.2%. ResMed Inc. has generated profits for 33 consecutive years.
What is RMD's earnings growth rate?
RMD compound annual EPS growth rates (CAGR): 1-Year: +37.4%, 3-Year: +21.5%, 5-Year: +17.4%, 10-Year: +14.4%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1993 to 2025.
What are RMD's profit margins?
ResMed Inc. net profit margin is +27.2%, operating margin is +32.7%, and gross margin is +59.4%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +25.9%.
Is RMD growing earnings?
Yes, RMD earnings are accelerating — EPS growth of +37.4% exceeds the 5-year CAGR of +17.4%. TTM net income reached $1.5B. Earnings momentum is strengthening.
What was RMD's best earnings year?
ResMed Inc.'s highest annual net income on record is $1.4B, achieved in fiscal year 2025. Earnings history on this page spans 1993 to 2025 and includes all annual and quarterly figures.
What were RMD's earnings last quarter?
RMD's most recent reported quarter was Q3 2026. Net income was $399M with diluted EPS of $2.71. For a full breakdown of all quarters, see the quarterly earnings table on this page.